Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Free Report) – Research analysts at Brookline Capital Management issued their FY2029 earnings per share estimates for Bioceres Crop Solutions in a research report issued on Tuesday, September 10th. Brookline Capital Management analyst K. Dolliver anticipates that the company will earn $1.55 per share for the year. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.30 per share.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last released its earnings results on Monday, September 9th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.20 by ($0.23). The company had revenue of $124.30 million for the quarter, compared to analyst estimates of $126.75 million. Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%. During the same period in the previous year, the firm earned ($0.06) earnings per share.
Read Our Latest Stock Analysis on Bioceres Crop Solutions
Bioceres Crop Solutions Trading Down 1.2 %
NASDAQ BIOX opened at $8.55 on Thursday. Bioceres Crop Solutions has a 52 week low of $8.16 and a 52 week high of $14.05. The firm has a 50 day moving average of $10.54 and a two-hundred day moving average of $11.47. The stock has a market capitalization of $536.91 million, a PE ratio of 855.00 and a beta of 0.49. The company has a quick ratio of 0.83, a current ratio of 1.22 and a debt-to-equity ratio of 0.29.
Hedge Funds Weigh In On Bioceres Crop Solutions
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Activest Wealth Management purchased a new position in Bioceres Crop Solutions during the 1st quarter worth $30,000. Cape Investment Advisory Inc. purchased a new position in shares of Bioceres Crop Solutions during the 4th quarter worth approximately $33,000. Oppenheimer & Co. Inc. acquired a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at approximately $139,000. Lazard Asset Management LLC purchased a new stake in shares of Bioceres Crop Solutions in the first quarter valued at approximately $212,000. Finally, Ping Capital Management Inc. acquired a new position in Bioceres Crop Solutions during the second quarter worth $448,000. 17.68% of the stock is currently owned by hedge funds and other institutional investors.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Read More
- Five stocks we like better than Bioceres Crop Solutions
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Analysts Recommend These 3 Sector ETFs for Long-Term Growth
- Canada Bond Market Holiday: How to Invest and Trade
- Can Roblox Really Grow to 1 Billion Active Daily Users?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Biotech Breakout: Stocks for Your Watchlist
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.